# Eliane Piaggio

Source: https://onco.cc/people/eliane-piaggio/  
OnCo record `eliane-piaggio` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Eliane Piaggio is an immunologist studying regulatory T cells and immune profiling to guide immunotherapy.

## Summary

Eliane Piaggio is Team Leader for Translational Immunotherapy at Institut Curie in Paris. An immunologist, her specialisms are tumour immunology, regulatory T cells and immunotherapy biomarkers. Her group characterises intratumoural regulatory T cells and the immune signatures that predict response to immunotherapy. Her papers include a study showing that PI3K pathway inhibition increases the immune infiltrate in muscle-invasive bladder cancer, a Nature Communications report that CD8+ T cell responsiveness to anti-PD-1 in melanoma is epigenetically regulated by Suv39h1, and a review of humanised mouse models for evaluating cancer immunotherapeutics. Her publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Team Leader, Translational Immunotherapy, Institut Curie
- Specialisms: Tumour immunology; Regulatory T cells; Immunotherapy biomarkers

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Piaggio%20E%5BAuthor%5D%20regulatory%20T%20cells%20tumor

## Connected records

- institutions: [Institut Curie](https://onco.cc/institutions/institut-curie/)
- pathways: [PD-1 / PD-L1 immune checkpoint & T-cell activation](https://onco.cc/pathways/pd1-checkpoint/)
- journals: [Oncoimmunology](https://onco.cc/journals/oncoimmunology/)

---
JSON: https://onco.cc/api/v1/entities/eliane-piaggio.json